2-azido-4-methoxybenzoic acid | 848142-85-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-azido-4-methoxybenzoic acid
• CAS: 848142-85-8
• 化学式: C₈H₇N₃O₃
• 分子量: 193.162
• InChiKey: RIHBTBQFQTUCFC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  60.9
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-azido-4-methoxybenzoic acid 在 吡啶 、 氯化亚砜 、 三氟二甲基硫醚络合物 作用下， 以 二氯甲烷 、 苯 为溶剂， 反应 53.25h， 生成 3-Chloro-2-(4-hydroxy-phenyl)-2H-indazol-6-ol
  参考文献：
  名称：

  Indazole Estrogens:  Highly Selective Ligands for the Estrogen Receptor β

  摘要：

  The estrogen receptors, ERalpha and ERbeta, are important pharmaceutical targets. To develop ERbeta-selective ligands, we synthesized a series of nonsteroidal compounds having a phenyl-2H-indazole core with different groups at C-3. Several of these show high affinity and good ERbeta selectivity, especially those with polar and/or polarizable substituents at this site (halogen, CF3, nitrile); the best compounds have affinities for ERbeta comparable to estradiol, with ERbeta affinity selectivity > 100. This potency and ERbeta selectivity is also seen in cell-based transcriptional assays, where several compounds showed ERbeta efficacies equivalent to that of estradiol with ERbeta potency selectivities of 100. These compounds might prove useful as selective pharmacological probes to study the biological actions of estrogens mediated through ERP, and they might lead to the development of useful pharmaceuticals. These findings also contribute to an evolving pharmacophore that characterizes certain nonsteroidal ligands having high ERbeta subtype affinity and potency selectivity.

  DOI：

  10.1021/jm049223g
• 作为产物：
  描述：

  2-氨基-4-甲氧基苯甲酸 在 sodium nitrite 、 sodium azide 作用下， 生成 2-azido-4-methoxybenzoic acid
  参考文献：
  名称：

  Divergent cyclization of 2-(5-iodo-1,2,3-triazolyl)benzamides toward triazole-fused lactams and cyclic imidates

  摘要：

  开发出了不同的 1,2,3-三唑融合杂环viachemoselective cyclization of 2-(5-iodotriazolyl)benzamides 方法，可控制 C-O 或 C-N 键的形成。

  DOI：

  10.1039/d3nj01264f

文献信息

• [EN] NOVEL CLOSTRIDIUM DIFFICILE TOXIN INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE TOXINE DE CLOSTRIDIUM DIFFICILE
  申请人：VENENUM BIODESIGN LLC

  公开号：WO2017214359A1

  公开（公告）日：2017-12-14

  The present invention relates to benzodiazepine derivative compounds of formula (I), or pharmaceutically acceptable salts thereof. The present benzodiazepine compounds are useful Clostridium difficile inhibitors in the treatment of Clostridium difficile infection in humans. The present invention provides a pharmaceutical composition containing benzodiazepine compounds of formula (I) and a method of making as well as a method of using the same in treating patients infected with Clostridium difficile infection by administering the same. The compounds of the present invention may be used in combination with additional antibiotics or anti-toxin antibody drugs.

  本发明涉及式(I)的苯二氮卓衍生物化合物，或其药学上可接受的盐。目前的苯二氮卓衍生物在治疗人类的克罗斯特氏梭菌感染中是有用的抑制剂。本发明提供了一种含有式(I)的苯二氮卓化合物的药物组合物，以及制备该药物组合物的方法和使用该药物组合物治疗感染克罗斯特氏梭菌的患者的方法。本发明的化合物可以与额外的抗生素或抗毒素抗体药物结合使用。
• Total Synthesis of Rutaecarpine and Analogues by Tandem Azido Reductive Cyclization Assisted by Microwave Irradiation
  作者：Ahmed Kamal、Nagula Shankaraiah、M. Reddy、T. Reddy、Leonardo Santos

  DOI：10.1055/s-0030-1259095

  日期：2011.1

  The total synthesis ofrutaecarpine and several analogues has been developed by using an azido reductive cyclization process starting from substituted azido benzoic acids. The intramolecular azido reductive cyclization step was performed with triphenylphosphine or Ni 2 B in HCl―MeOH (1 M) using microwave irradiation. This synthetic route is amenable for the generation of a library of quinazolinone compounds

  已经通过使用从取代的叠氮基苯甲酸开始的叠氮基还原环化过程开发了芸香果芸香碱和几种类似物的全合成。分子内叠氮基还原环化步骤使用三苯基膦或 Ni 2 B 在 HCl-MeOH (1 M) 中使用微波辐射进行。该合成路线适用于生成喹唑啉酮化合物库。
• Clostridium difficile toxin inhibitors
  申请人：Venenum Biodesign, LLC

  公开号：US10669242B2

  公开（公告）日：2020-06-02

  The present invention relates to benzodiazepine derivative compounds of formula (I), or pharmaceutically acceptable salts thereof. The present benzodiazepine compounds are useful Clostridium difficile inhibitors in the treatment of Clostridium difficile infection in humans. The present invention provides a pharmaceutical composition containing benzodiazepine compounds of formula (I) and a method of making as well as a method of using the same in treating patients infected with Clostridium difficile infection by administering the same. The compounds of the present invention may be used in combination with additional antibiotics or anti-toxin antibody drugs.

  本发明涉及式（I）的苯二氮杂卓衍生物化合物或其药学上可接受的盐类。本发明的苯二氮杂卓化合物是治疗人类艰难梭菌感染的有用的艰难梭菌抑制剂。本发明提供了一种含有式（I）苯并二氮杂卓化合物的药物组合物及其制造方法，以及通过给药治疗感染艰难梭菌的患者的方法。本发明的化合物可与其他抗生素或抗毒素抗体药物联合使用。
• Novel Clostridium Difficile Toxin Inhibitors
  申请人：Venenum Biodesign, LLC

  公开号：US20190194147A1

  公开（公告）日：2019-06-27

  The present invention relates to benzodiazepine derivative compounds of formula (I), or pharmaceutically acceptable salts thereof. The present benzodiazepine compounds are useful Clostridium difficile inhibitors in the treatment of Clostridium difficile infection in humans. The present invention provides a pharmaceutical composition containing benzodiazepine compounds of formula (I) and a method of making as well as a method of using the same in treating patients infected with Clostridium difficile infection by administering the same. The compounds of the present invention may be used in combination with additional antibiotics or anti-toxin antibody drugs.
• [EN] BENZODIAZEPINE GCNF MODULATORS FOR STEM CELL MODULATION<br/>[FR] MODULATEURS DU GCNF A LA BENZODIAZEPINE DESTINES A MODULER LES CELLULES SOUCHES
  申请人：PHARMACOPEIA INC

  公开号：WO2007095495A2

  公开（公告）日：2007-08-23

  [EN] A genus of benzodiazepines that modulate Germ Cell Nuclear Factor (GCNF) is disclosed. The compounds are useful to regulate stem cell differentiation and as contraceptives. Other embodiments are also disclosed.
  [FR] La présente invention concerne un genre de benzodiazépines qui module le facteur nucléaire de cellules germinales (GCNF). Les composés servent à réguler la différentiation des cellules souches et servent également de contraceptif. L'invention a également trait à d'autres modes de réalisation.